Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study

Overview of attention for article published in British Journal of Haematology, May 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 13 Mendeley

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 15,722 followers.

RT @DrOlaLandgren: Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study…

Subgroup analysis based on cytogenetic risk in patients with relapsed or refractory multiple myeloma in the CANDOR study. #mmsm ⁦@IMFmyeloma⁩ ⁦@myelomacrowd⁩ ⁦@theMMRF⁩ ⁦@SylvesterCancer⁩ https://t.co/0VQVG9Nqr1

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.